The vaccine targets a protein expressed by tumor blood cells

After 15 years of research, scientists at Cancer Center Amsterdam have developed a new cancer vaccine for dogs

The vaccine targets a tumor protein called vimentin, creating an immune response in dogs with bladder cancer

“The development of this vaccine for the treatment of cancer in humans is promising,” said cancer researcher Arjan Griffioen

Using the body’s own immune system to fight cancer — immunotherapy — has shown success against formerly intractable forms of the disease

Immunotherapy techniques include administering monoclonal antibodies, arming T cells to attack cancer

While the immune system is a formidable army indeed, tumors are a particularly hardened target

Tumor cells deploy a number of measures to block, defang, or become invisible to our immune system